BSX - Boston Scientific Corporation

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue9,048,0008,386,0007,477,0007,308,000
Cost of Revenue2,606,0002,447,0002,176,0002,216,000
Gross Profit6,442,0005,939,0005,301,0005,092,000
Operating Expenses
Research Development997,000920,000876,000817,000
Selling General and Administrative3,281,0003,083,0002,847,0002,878,000
Non Recurring----
Others----
Total Operating Expenses7,449,0006,995,0006,394,0006,349,000
Operating Income or Loss1,599,0001,391,0001,083,000959,000
Income from Continuing Operations
Total Other Income/Expenses Net-667,000-1,214,000-1,733,000-1,468,000
Earnings Before Interest and Taxes1,599,0001,391,0001,083,000959,000
Interest Expense-229,000-233,000-284,000-216,000
Income Before Tax932,000177,000-650,000-509,000
Income Tax Expense828,000-170,000-411,000-390,000
Minority Interest----
Net Income From Continuing Ops104,000347,000-239,000-119,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income104,000347,000-239,000-119,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares104,000347,000-239,000-119,000